Literature DB >> 3472486

Expression of human immunodeficiency virus in cerebrospinal fluid of children with progressive encephalopathy.

L G Epstein, J Goudsmit, D A Paul, S H Morrison, E M Connor, J M Oleske, B Holland.   

Abstract

The retrovirus that causes acquired immune deficiency syndrome (AIDS) is now designated the human immunodeficiency virus (HIV). The cerebrospinal fluid (CSF) of 27 children with HIV infection was assayed for intra-blood-brain barrier (IBBB) synthesis of HIV-specific antibodies and for the presence of HIV antigen. In this cohort, 11 children had a progressive encephalopathy (PE), 9 had a static encephalopathy (SE), and 7 had normal neurological findings (N). IBBB synthesis of HIV-specific antibodies was identified (using matched serum and CSF specimens) in 7 of 11 children with PE, 4 of 9 children with SE, and 2 of 7 children with N. HIV antigen was found (using a highly sensitive solid-phase enzyme immunoassay) in the CSF of 8 of 11 children with PE, none of the children with SE, and none of the 7 children with N. On the basis of these data, we conclude that: IBBB synthesis of HIV antibodies indicates invasion of the central nervous system but may reflect prior or current infection; and HIV antigen in CSF indicates viral expression and correlates with the occurrence of PE. These findings strongly implicate HIV as the causative agent of PE in these children. The assay for HIV antigen in the CSF may be of value in determining the prognosis of children with HIV infection and for evaluating the efficacy of therapeutic agents against this retrovirus.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3472486     DOI: 10.1002/ana.410210413

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  13 in total

1.  Chronic HIV encephalitis--II. Clinical aspects.

Authors:  S Poser; W Lüer; D Eichenlaub; H D Pohle; T Weber; S Jürgens; K Felgenhauer
Journal:  Klin Wochenschr       Date:  1988-01-04

Review 2.  Pediatric human immunodeficiency virus infection.

Authors:  J B Domachowske
Journal:  Clin Microbiol Rev       Date:  1996-10       Impact factor: 26.132

Review 3.  Vertical human immunodeficiency virus-1 infection: involvement of the central nervous system and treatment.

Authors:  C Exhenry; D Nadal
Journal:  Eur J Pediatr       Date:  1996-10       Impact factor: 3.183

Review 4.  Diagnosis and management of opportunistic infections in childhood AIDS.

Authors:  S Lal; D Sengupta
Journal:  Indian J Pediatr       Date:  1994 Sep-Oct       Impact factor: 1.967

5.  Cerebrospinal fluid HIV-1 p24 antigen and culture: sensitivity and specificity for AIDS-dementia complex.

Authors:  B J Brew; M O Paul; G Nakajima; A Khan; H Gallardo; R W Price
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-07       Impact factor: 10.154

Review 6.  AIDS-dementia-complex: pathology, pathogenesis and future directions.

Authors:  M C Dal Canto
Journal:  Ital J Neurol Sci       Date:  1989-06

7.  Longitudinal analysis of monocyte/macrophage infection in simian immunodeficiency virus-infected, CD8+ T-cell-depleted macaques that develop lentiviral encephalitis.

Authors:  Stephanie J Bissel; Guoji Wang; Anita M Trichel; Michael Murphey-Corb; Clayton A Wiley
Journal:  Am J Pathol       Date:  2006-05       Impact factor: 4.307

8.  Declining incidence of AIDS dementia complex after introduction of zidovudine treatment.

Authors:  P Portegies; J de Gans; J M Lange; M M Derix; H Speelman; M Bakker; S A Danner; J Goudsmit
Journal:  BMJ       Date:  1989-09-30

Review 9.  Neurologic and psychiatric manifestations of HIV disease.

Authors:  H Hollander
Journal:  J Gen Intern Med       Date:  1991 Jan-Feb       Impact factor: 5.128

Review 10.  Cerebrospinal fluid (CSF) analyses in HIV-1 primary neurological disease.

Authors:  J Nogales-Gaete; K Syndulko; W W Tourtellotte
Journal:  Ital J Neurol Sci       Date:  1992-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.